Achyut Healthcare Peer Comparison

BSE: 543499

₹6.98

₹0.08 (1.16%)

As on 04-Sep-2026IST

Market cap

₹168 Cr

Revenue (TTM)

₹3 Cr

P/E Ratio

531.4

P/B Ratio

4.8

Div. Yield

0 %

Edit

	Achyut Healthcare	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
Market cap (₹ Cr)	168	33,908	29,353	28,517	25,923
Revenue (₹ Cr)	3	3,564	1,936	9,205	1,462
Net Profit (₹ Cr)	0.55	414.00	288.22	-371.81	387.35
Net Margin (%)	13.80	11.23	14.79	-3.93	26.01
RoE (%)	1.77	8.38	29.77	-3.85	25.18
Price to Earnings	531.44	82.90	101.84	--	67.12
Price-To-Book	4.79	6.74	21.87	3.56	15.02

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Achyut Healthcare	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
Operating Revenue	3.05	3,012.00	1,284.27	9,151.18	1,006.88
Total Income	3.97	3,074.00	1,296.22	9,312.95	1,023.80
Total Expenditure	3.25	2,619.00	1,028.33	7,733.31	774.80
EBITDA	-0.20	393.00	255.95	1,417.87	232.07
Depreciation	0.02	217.00	36.59	816.34	26.62
EBIT	-0.22	176.00	219.36	601.53	205.45
Interest	0.00	254.00	36.78	421.59	6.22
Other Income	0.92	62.00	11.95	161.77	16.93
Exceptional Items	--	--	--	--	--
Profit before Tax	0.70	-16.00	194.52	414.64	216.16
Provision for Tax	0.16	41.00	60.16	323.51	55.75
Profit after Tax	0.55	-57.00	134.36	91.13	160.42

Liabilities (₹ Cr)

	Achyut Healthcare	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
Shareholder's Funds	31.30	4,353.00	540.98	8,125.47	1,309.63
Minority Interest	--	304.00	0.00	--	10.45
Non-Current Liabilities	-0.01	887.00	122.65	3,392.72	26.93
Current Liabilities	1.29	2,042.00	786.03	3,850.56	202.25
Total Liabilities	32.59	8,100.00	1,451.43	15,513.53	1,549.26

Assets (₹ Cr)

	Achyut Healthcare	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
Non-Current Assets	20.52	5,017.00	386.29	9,487.47	757.63
Current Assets	12.06	2,465.00	1,063.37	5,881.28	791.64
Total Assets	32.59	8,100.00	1,451.43	15,513.53	1,549.26
Total Debt*	0.00	1,859.00	393.17	4,720.27	8.18
Net Current Assets	10.76	423.00	277.34	2,030.72	589.39
Contingent Liabilities	--	770.26	12.25	99.76	15.38

Cashflow (₹ Cr)

	Achyut Healthcare	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
Cash From Operating Activities	-4.06	-22.00	159.18	892.30	118.34
Cash Flow from Investing Activities	4.69	-783.00	-64.81	-477.46	-223.94
Cash from Financing Activities	--	409.00	-39.81	-440.83	261.12
Net Cash Inflow / Outflow	0.62	-396.00	54.56	-25.99	155.52

Ratios

Profitability Ratios

	Achyut Healthcare	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
ROCE (%)	2.27	4.07	26.97	6.61	20.14
ROE (%)	1.77	-1.48	30.68	1.14	16.19
ROA (%)	1.72	-0.78	10.50	0.60	12.13
EBIT Margin (%)	23.63	15.11	20.86	17.26	24.73
Net Margin (%)	13.80	-1.85	10.37	0.98	15.67
Cash Profit Margin (%)	18.48	4.14	7.13	8.54	18.58

Growth Ratios

	Achyut Healthcare	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
Revenue Growth (%)	-50.34	7.65	50.40	11.99	40.34
EBIT Growth (%)	-4.32	272.95	54.77	15.16	83.12
Net Profit Growth (%)	9.04	87.92	47.63	411.39	229.35
EPS Growth (%)	9.39	90.35	45.69	410.84	67.16
Book Value Growth (%)	1.78	29.77	42.49	2.28	94.96

Valuation Ratios

	Achyut Healthcare	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
Price / Earnings	140.21	0.00	0.00	326.26	62.97
Price / Book Value	2.45	5.31	0.00	3.69	15.26
Dividend Yield (%)	0.00	0.00	--	0.06	0.06
EV/EBITDA	105.26	54.36	1.09	21.49	79.31
Market Cap (₹ Cr)	76.79	23,064.69	0.00	29,731.27	19,988.69

Solvency Ratios

	Achyut Healthcare	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
Debt to Equity	0.00	0.43	0.76	0.59	0.01
Short term debt to equity ratio	--	0.11	0.54	0.12	0.01
Current Ratio	9.32	1.21	1.35	1.53	3.91
Quick Ratio	9.18	0.85	0.69	0.93	3.02
Interest Coverage	704.50	0.94	6.29	1.98	35.76

Operating Efficiency Ratios

	Achyut Healthcare	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
Debtors to sales (%)	44.02	21.95	25.21	25.67	28.85
Asset Turnover	0.10	0.53	1.87	0.70	0.76
Receivable days	105.12	60.36	47.59	77.05	90.06
Inventory Days	14.55	64.42	62.58	77.13	61.02
Payable days	83.52	218.94	228.78	173.49	96.06
Cash Conversion Cycle	36.15	-94.15	-118.62	-19.30	55.02

Annual
Quarterly